Skip to main navigation Skip to search Skip to main content

Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C

  • Mikio Mikami
  • , Sachiko Ezawa
  • , Naoko Sakaiya
  • , Yuuki Komuro
  • , Chisei Tei
  • , Takeshi Fukuchi
  • , Makio Mukai

Research output: Contribution to journalArticlepeer-review

Abstract

Among patients with uterine cervical cancer, glassy-cell carcinoma is very rare. The disease occurs mainly in younger patients, is rapidly progressive, and has a poor prognosis. We describe a case of glassy-cell carcinoma of the uterine cervix, in which preoperative intra-arterial chemotherapy was surprisingly effective.

Original languageEnglish
Pages (from-to)1159-1160
Number of pages2
JournalLancet
Volume355
Issue number9210
DOIs
Publication statusPublished - 2000 Apr 1
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C'. Together they form a unique fingerprint.

Cite this